byiShook Opinion
Nov 12, 2024 - 11:15
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, but AstraZeneca stock slipped amid a criminal probe in China. The post AstraZeneca Stock Dives As China's Criminal Probe Rattles Its Third-Quarter Beat appeared first on Investor's Business Daily.
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, but AstraZeneca stock slipped amid a criminal probe in China.
The post AstraZeneca Stock Dives As China's Criminal Probe Rattles Its Third-Quarter Beat appeared first on Investor's Business Daily.